The purpose of this research study is to demonstrate a lack of effect of multiple doses of GSK189075 on the PK of an oral contraceptive pill in healthy female subjects. To estimate the effects of GSK189075 on hormonal levels and on birth control.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
22
GSK Investigational Site
Miramar, Florida, United States
Oral contraceptive pill (OC) drug levels
Time frame: over 24h starting on Day 14
blood hormone levels
Time frame: on Days 1, 11-14, & 21 of Periods 1 (OC alone) & 3 (OC plus GSK study drug). Period 2 is GSK drug study alone.
Adverse events
Time frame: all visits after study drug
ECGs, Clinical laboratory tests
Time frame: screening & follow-up
vital signs
Time frame: screening;Day 13, Period 1 & 3; Follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.